The invention relates to a composite which is composed of (2Z, 8Z, 10E)-2,8,10-
pentadecane triene-4,6-diyne-1-
alcohol and (2Z, 8E, 10E)-2,8,10-
pentadecane triene-4,6-diyne-1-
alcohol according to the proportion of 1:(1-4) or is composed of (2Z, 8Z, 10E)-2,8,10-
heptadecane triene-4,6-diyne-1-
alcohol and (2Z, 8E, 10E)-2,8,10-
heptadecane triene-4,6-diyne-1-alcohol according to the proportion of 1:(1-4). The composite disclosed by the invention is obtained by being extracted and separated from
traditional Chinese medicine radix bupleuri. The result of an in-vitro
monoamine neurotransmitter reuptake inhibition experiment shows that the composite disclosed by the invention has triple inhibition effects on the
reuptake of 5-HT (5-Hydroxytryptamine), NA (noradrenalin) and DA (
Dopamine), is higher than the effective part of ease
powder petroleum ether and the part of
radix bupleuri petroleum ether in inhibition ratio and is higher than
positive control drugs, namely
fluoxetine, norpramin and 6-hydroxydopamine, in inhibiting effect. According to the invention, two composites can be applied to prepare a
drug used for preventing and curing depression.